High density of tryptase‐positive mast cells in human colorectal cancer: a poor prognostic factor related to protease‐activated receptor 2 expression
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Tryptase(+) mast cells (MC s), abundant in the invasive front of tumours, contribute to tissue remodelling. Indeed, protease‐activated receptor‐2 (PAR‐2) activation by MC‐tryptase is considered an oncogenic event in colorectal cancer (CRC). Recently, we have suggested NHERF 1 as a potential new marker in CRC. In this study, we aimed to determine the distribution of tryptase(+)MC s and PAR‐2 and to examine the relationship between PAR‐2 and NHERF 1, investigating their reputed usefulness as tumour markers. We studied a cohort of 115 CRC specimens including primary cancer (C) and adjacent normal mucosa (NM) by immunohistochemical double staining, analyzing the protein expression of MC‐tryptase,PAR‐2 and cytoplasmic NHERF 1.MC density was higher in NM than in C. Tumours with high TNM stage and poor grade showed the highest MC density. A higher PAR‐2 immunoreactivity characterized tumours most infiltrated by MC s compared with samples with low MC density. Furthermore,PAR‐2 overexpression was associated with advanced TNM stage, poor grade and lymphovascular invasion (LVI). A positive correlation existed between tryptase(+)MC density and PAR‐2 expression. Cytoplasmic NHERF 1 was higher in C than in NM and overexpressing tumours resulted associated with nodal and distant metastases, poor grade and LVI.PAR‐2 correlated with cytoplasmic NHERF 1 and the PAR‐2(+)/cytoplasmic NHERF 1(+) expression immunophenotype identified tumours associated with unfavourable prognosis and aggressive clinical parameters. Our data indicate that the high density of tryptase(+)MC s at invasive margins of tumours was associated with advanced stages of CRC and was strongly correlated with PAR‐2 expression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mast cell tryptase stimulates the synthesis of type I collagen in human lung fibroblasts
Cairns, J. A., & Walls, A. F. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119290 · Cited by 318 · cited 1×
“Tryptase(+) MCs have been demonstrated to play a role in tissue remodelling during wound healing and cancer, degrading selectively matrix proteins, synthesizing collagen [35] and stimulating Table 2 Association between tumour marker expressions and clinicopathological data in 115 colorectal cancers”
BackgroundThe differentiation and function of myofibroblasts is regulated by mast cell mediators
Gailit, J., Marchese, M. J., Kew, R. R., & Gruber, B. L. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2001.15211.x · Cited by 174 · cited 1×
“fibroblast proliferation [36] and myofibroblast differentiation [25].”
ESTROGEN REGULATES CYTOKINE RELEASE IN HUMAN MAST CELLS
Kim, M.-S., Chae, H.-J., Shin, T.-Y., Kim, H.-M., & Kim, H.-R. (2001) · Immunopharmacology and Immunotoxicology · doi:10.1081/iph-100108596 · Cited by 65 · cited 1×
“This strong association seems to be related to the oestrogen/oestrogen receptor/tumour necrosis factor-a axis; in fact, MCs express oestrogen receptors and treatment with the specific ligand has been demonstrated to prevent the release of TNF-alpha, a major MC-derived autocrine growth factor [34].”
Background
Cited by
The role of myeloid cells in cancer therapies
Engblom, C., Pfirschke, C., & Pittet, M. J. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.54 · Cited by 788
Role of Mast Cells in Shaping the Tumor Microenvironment
Komi, D. E. A., & Redegeld, F. A. (2020) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-019-08753-w · Cited by 362
Tumor-Infiltrating Immune Cells Act as a Marker for Prognosis in Colorectal Cancer
Ye, L., Zhang, T., Kang, Z., Guo, G., Sun, Y., Lin, K., Huang, Q., Shi, X., Ni, Z., Ding, N., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02368 · Cited by 332
Are Mast Cells MASTers in Cancer?
Varricchi, G., Galdiero, M. R., Loffredo, S., Marone, G., Iannone, R., Marone, G., & Granata, F. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00424 · Cited by 323
New perspectives on the origins and heterogeneity of mast cells
St. John, A. L., Rathore, A. P. S., & Ginhoux, F. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-022-00731-2 · Cited by 126
Metadata
- Authors
- Malfettone, A., Silvestris, N., Saponaro, C., Ranieri, G., Russo, A., Caruso, S., Popescu, O., Simone, G., Paradiso, A., & Mangia, A.
- Venue
- Journal of Cellular and Molecular Medicine
- Publisher
- Wiley
- Published
- 2013-08
- Volume
- 17
- Issue
- 8
- Pages
- 1025-1037
- ISSN
- 1582-1838 (ISSN-L)
- 1582-4934
- OpenAlex
- W2070845471
- Cited by
- 102
- References
- 3
- FWCI
- 4.09
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: High density of tryptase‐positive mast cells in human colorectal cancer: a poor prognostic factor related to protease‐activated receptor 2 expression. https://app.cochat.ai/papers/10.1111/jcmm.12073
- The paper
- Malfettone, A., Silvestris, N., Saponaro, C., Ranieri, G., Russo, A., Caruso, S., Popescu, O., Simone, G., Paradiso, A., & Mangia, A. (2013). High density of tryptase‐positive mast cells in human colorectal cancer: a poor prognostic factor related to protease‐activated receptor 2 expression. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.12073
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.